1AI — Algorae Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$18.23m
- AU$14.29m
- AU$0.08m
Brief: Algorae Pharmaceuticals Provides NTCELL Project Update
Brief: Algorae Pharmaceuticals Says Agreement With Hl Pharma
Brief: Algorae Pharmaceuticals Executed Deal With University Of New South Wales
Australia's Living Cell Tech jumps on Parkinson's disease trail progress
Brief: Living Cell Technologies Undertakes A$2.5 Mln Capital Raise Initiative
Brief: Living Cell Technologies Seeks Trading Halt
Brief: Living Cell Technologies Says David Hainsworth Appointed Executive Chairman
Brief: Living Cell Technologies Says Bernie Tuch Will Continue As Interim CEO Until End Of Jan 2023
Australia's Living Cell Technologies hits over 1-year high on new AI milestone
Brief: Living Cell Technologies Completes $1.285 Mln Placement
Brief: Living Cell Technologies Seeks Trading Halt
Brief: Living Cell Technologies Says Agreement Signed With Opticellai Pty To Facilitate Collaborative Research Efforts
Australia Stock Exchange release from LIVING CELL TECH : Notice of General Meeting/ Proxy Form
Australia Stock Exchange release from LIVING CELL TECH : Funding Update-LCT Advancing NTCELL with Investor Backing
Australia Stock Exchange release from LIVING CELL TECH : Investor Presentation
Australia Stock Exchange release from LIVING CELL TECH : Investor Webinar
Brief: Living Cell Technologies Ltd Chair Bernie Tuch Has To Continue As Interim CEO
Australia Stock Exchange release from LIVING CELL TECH : Change of Address
Australia Stock Exchange release from LIVING CELL TECH : LCT Interim CEO Term Extended as NTCELL Advances